Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for Yeztugo® (lenacapavir) 300-mg tablet as a ...
New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
The Hearty Soul on MSN
New diabetes treatment may replace insulin injections with sweet treat
A new oral insulin embedded in sugar-free chocolate uses nano-carriers to target the liver, cutting hypoglycemia risk. The ...
Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients. Conduit has developed a series of novel, advantageous ...
Despite effective vaccines, the COVID-19 pandemic continues on. Indeed, experts are closely monitoring the emergence of new variants and continuous waves of new cases around the globe. To this end, ...
Quotient Sciences has announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) - a landmark achievement highlighting the ...
Nanotechnology Toothpaste Formulations Market is estimated to grow to USD 980.6 Mn by 2036. with CAGR of 6.5% during the ...
The global nanotechnology toothpaste formulations market is entering a new phase of growth as preventive healthcare becomes a ...
In this podcast, Pharma and Drug Delivery executives from Novartis, AstraZeneca, Merck and Quotient Sciences discuss traditional and novel approaches to improve the oral delivery of peptides including ...
SASKATOON, Saskatchewan--(BUSINESS WIRE)--ZYUS Life Sciences Inc. ("ZYUS"), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results